Patent Picks—Chia Seed Extract, Bayberry Extract; Retinoids, Adapalene, Coumarin and More for Skin Lightening

By: Katie Anderson (Schaefer), Cosmetics & Toiletries magazine

Posted: September 14, 2011

page 4 of 5

The composition according to the invention may especially be a skin care product or a makeup product, especially a foundation. It is commonplace for people with colored skin, or with pigmentation marks, red blotches or shadows under the eyes, to wish to correct these types of cutaneous dyschromia, and for this purpose use cosmetic or dermatological compositions that allow the complexion to be lightened and unified. To this end, it is known practice to use cosmetic compositions containing bleaching agents. However, it is necessary, to use these agents for a prolonged period and in large amounts in order to observe a bleaching effect on the skin. Furthermore, an effect is not observed immediately on application of the compositions comprising them. For the purpose of immediate lightening and unifying of the complexion, it is also known practice to use cosmetic compositions containing fluorescent compounds, with a particular focus on optical brighteners.

A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation
WIPO Patent Application WO/2011/098391
Publication Date: Aug. 18, 2011
Assignee: Galderma Research & Development, J-C Dhun, N Kerrouche and P Soto

A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- Caucasian population with decrease of post- inflammatory hyperpigmentation, keloid scarring and acne hyperpigmented macules and cystic lesions. Acne vulgaris, also known as polymorphic acne is most common. It includes four stages, but passage through all stages is not obligatory: Stage 1 corresponds to acne with comedones characterized by a large number of open comedones and/or closed, and microcysts; stage 2 or papulopustular acne is mild to moderate, characterized by the presence of open comedones and/or closed, microcysts, but also red papules and pustules and mainly affects the face and leaves little scarring; and stage 3 or papulocomedonienne acne is more severe and extends to the back, chest and shoulders and is accompanied by a greater number of scars.

Compositions and methods for reducing appearance of under-eye dark circles
WIPO Patent Application WO/2011/097617
Publication Date: Aug. 11, 2011
Assignee: ELC Management LLC and DB YAROSH

A cosmetic or dermatological composition is provided for reducing appearance of under-eye dark circles that contains at least one bicyclic monoterpene diol and at least one skin lightening agent in a cosmetically or pharmaceutically acceptable carrier. The composition may further contain at least one anti-angiogenic agent and/or at least one anti-inflammatory agent.